FDMT – 4d molecular therapeutics, inc. (US:NASDAQ)
Stock Stats
News
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) had its price target lowered by analysts at Bank of America Co. from $79.00 to $46.00. They now have a "buy" rating on the stock.
4DMT Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in IOVS [Yahoo! Finance]
4DMT Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in IOVS
4D Molecular Therapeutics, Inc. (FDMT): An Oversold Healthcare Stock to Invest In Now [Yahoo! Finance]
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) is now covered by analysts at Morgan Stanley. They set an "underweight" rating and a $8.00 price target on the stock.
Form 8-K 4D Molecular Therapeutic For: Dec 06
Form 4 4D Molecular Therapeutic For: Dec 09 Filed by: Kolchinsky Peter
Form SC 13G/A 4D Molecular Therapeutic Filed by: BlackRock, Inc.
Form 3 4D Molecular Therapeutic For: Nov 13 Filed by: Kolchinsky Peter
Form SC 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.